News Sentiment

MIRM sentiment intelligence

Mirum Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 53 Balanced news tone 63 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 118.86 Week of 17 Jul 2026
Weighted tone 53/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

83/100 classification confidence.

Company focus 54

directly relevant articles

Source quality 1

high-authority source matches

Trend context Trend active

-2.7% over one week, +10.9% over four weeks, trend active, and materially above fair value.

Latest direct headline Neutral

Mirum Pharmaceuticals (MIRM) Stock Looks Fully Valued On Current Sales Expectations

Market Reaction

Balanced read

63/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 83/100 classification
One-week reaction -2.7% Price reacting lower
Trend fit Trend active 10.9% over four weeks
Fair value 124.0% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 16
Neutral 39
Negative 8

Relevance

Why the article matched

Direct first
Direct company coverage 54
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Market source 14
Stock Titan 9
simplywall.st 6
TradingView 6
Moomoo 3
Investing.com 3
Trefis 3
Business Wire 2

Event Lens

What the news is about

Classified themes
Market update 40
Earnings 16
Analyst action 3
Deals and strategy 3
Balance sheet 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-60 of 63
Stock Titan Direct company coverage

2,721 performance shares proposed; Jolanda Howe sold 2,594 (MIRM)

A Form 144 filing by Morgan Stanley Smith Barney LLC Executive Financial Services discloses a proposed resale of 2,721 performance shares of Mirum Pharmaceuticals, Inc. (MIRM) dated March 15, 2026. The filing also reports that Jolanda Marie Howe previously sold 2,594 common share

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 21:39
Source
Stock Titan
TradingView Direct company coverage

Price to sales forward of Mirum Pharmaceuticals, Inc. – NASDAQ:MIRM

This page from TradingView provides financial information for Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), specifically focusing on its forward price-to-sales ratio. The content appears to be a financial data point within a larger platform, showing the company's value for a specifi

Tone
Neutral 50/100
Event
Market update
Published
01 Jul 2026 19:44
Source
TradingView
Trefis Direct company coverage

Mirum Pharmaceuticals Stock Surges 25%, With A 9-Day Winning Spree

Mirum Pharmaceuticals (MIRM) recently experienced a 9-day winning streak, with its stock surging 25% and its market cap increasing by about $1.4 billion to $7.3 billion. While the company demonstrates strong operating performance, its current valuation is considered very high, ma

Tone
Positive 66/100
Event
Market update
Published
29 Jun 2026 14:40
Source
Trefis
TradingView Direct company coverage

Price to book forward of Mirum Pharmaceuticals, Inc. – NASDAQ:MIRM

This article provides financial information for Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM), focusing on its forward price-to-book ratio. It appears to be a stub or an entry from a financial data platform, indicating the company's financials, news, community, technicals, and foreca

Tone
Neutral 50/100
Event
Market update
Published
29 Jun 2026 14:40
Source
TradingView